# Guaifenesin

NDC: 69848-017
Generic name: Guaifenesin
Labeler / Manufacturer: GRANULES USA, INC.
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20211231

FDA application: ANDA213420

## Active ingredients

- GUAIFENESIN: 600 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69848-017"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69848-017
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a62d427e-f339-f225-e053-2a95a90ab387